All In Biotech

Drug Trial Radar · NCT00243815

Use of Ibuprofen to Prevent IUD Site Effects

Prophylactic Ibuprofen: Effect on IUD Continuation Rates

Last checked: Nov 19, 2026Latest source record: Oct 17, 2006 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 2,019 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,019

Actual

Start

Jun 2002

Primary completion

Not stated

Study completion Nov 2004

Sponsor

Lead sponsor
FHI 360Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Chilean Institute of Reproductive Medicine; Ministry of Health, Chile
First posted
Oct 25, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
Double
Primary purpose
Prevention
Who can join
Female only, from 18 years, up to 49 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This research will determine whether prophylactic use of ibuprofen can prevent common side effects of the copper intrauterine device (IUD) and prevent early removal of the device.

Conditions

  • IUD Removal

Interventions

  • ibuprofenDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. IUD removal

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • 43 Ministry of Health facilities

    Santiago, Chile

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.